| Value | ₹5.29 Cr |
|---|
BSE filing, NSE: DMART. Summary written from the filing by ALFA Finder's alert engine.
Avenue Supermarts Ltd: key numbers
- Share price
- ₹3,133.90
- Market cap
- ₹2,04,427 Cr
- Revenue (annual)
- ₹68,821 Cr
- Net profit (annual)
- ₹2,970 Cr
- P/E (TTM)
- 65.6×Sector 62.0×
- Promoter holding
- 74.48%+0.00% QoQ
- FII holding
- 8.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Avenue Supermarts Ltd
All →Avenue Supermarts Other Announcement
Avenue Supermarts disclosed PIT Reg 7(2) trades by designated persons, mainly pledge invocations to repay ESOP loans. Aggregate disclosed value is about Rs 2.24 Crore.
- Value
- ₹2.24 Cr
Avenue Supermarts Legal & Regulatory
Avenue Supermarts was penalised Rs.55.75 lakhs by GIFT City authority for project completion delays. The company is evaluating the penalty letter and says operations are unaffected.
- Value
- ₹0.56 Cr
Avenue Supermarts Other Announcement
Avenue Supermarts disclosed two designated persons' pledge invocations to repay ESOP exercise loans. Shares disposed on 22 October 2026 were worth a combined Rs.1.89 Crore.
- Value
- ₹1.89 Cr
Avenue Supermarts Other Announcement
Avenue Supermarts disclosed insider trading filings involving designated persons. These disclosures detail recent market sales and pledge invocations of equity shares.
- Value
- ₹0.46 Cr
Avenue Supermarts Promoter Reclassification
Avenue Supermarts announced the reclassification of Mr. Vijay Shankar Chandak from the Promoter Group to the Public category, following receipt of exchange no-objection certificates.
Avenue Supermarts Investor Presentation: Key Takeaways
Avenue Supermarts Limited reported H1 FY27 results with Revenue from Operations at ₹37,550 Crs and PAT at ₹1,739 Crs. The company continues its cluster-based expansion, reaching 518 stores.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.